Immu-Mela is an open-access resource for interactive exploration of a variety of known and novel genomic signatures predictive of immunotherapy response across multiple datasets in melanoma.
These are source data files comprising the single-cell immunofluorescent staining intensities for all cells in each tumor of the 4 Moffitt Cancer Center patients analyzed in Figs. 7bi, 7bii, and 7biii
The MOUSEION-010 Meta-Analysis assessed the association between nutritional status and clinical outcomes such as Progression Free Survival (PFS) and Overall Survival (OS) among cancer patients treated
